Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-16-004248
Filing Date
2016-04-14
Accepted
2016-04-14 16:52:13
Documents
34
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mjpharmaceuticals10k123115.htm 10-K 506101
2 EX-31.1 ex31-1.htm EX-31.1 11137
3 EX-31.2 ex31-2.htm EX-31.2 10936
4 EX-32.1 ex32-1.htm EX-32.1 6908
5 EX-32.2 ex32-2.htm EX-32.2 6088
  Complete submission text file 0001185185-16-004248.txt   1235147

Data Files

Seq Description Document Type Size
6 EX-101.INS mela-20151231.xml EX-101.INS 70890
7 EX-101.SCH mela-20151231.xsd EX-101.SCH 12782
8 EX-101.CAL mela-20151231_cal.xml EX-101.CAL 10588
9 EX-101.DEF mela-20151231_def.xml EX-101.DEF 64547
10 EX-101.LAB mela-20151231_lab.xml EX-101.LAB 78727
11 EX-101.PRE mela-20151231_pre.xml EX-101.PRE 66998
Mailing Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056
Business Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056 214-505-3839
MJ Pharmaceuticals Inc. (Filer) CIK: 0001502629 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54811 | Film No.: 161572256
SIC: 7389 Services-Business Services, NEC